Literature DB >> 21771876

Notch1 expression, which is related to p65 Status, is an independent predictor of prognosis in colorectal cancer.

Dake Chu1, Yi Zhou, Zixi Zhang, Yuming Li, Jipeng Li, Jianyong Zheng, Hongwei Zhang, Qingchuan Zhao, Weizhong Wang, Rui'an Wang, Gang Ji.   

Abstract

PURPOSE: Notch1 has been proven to be aberrantly expressed in colorectal cancer and related to tumor differentiation status. However, few previous studies concentrated on the predictive role of Notch1 expression on the overall survival of patients with colorectal cancer. This study explored expression of Notch1 and its relationship with p65 and prognosis in colorectal cancer. EXPERIMENTAL
DESIGN: Two independent study cohorts were involved in the present study. Clinical specimens from 941 eligible patients were constructed into tissue microarrays. The expression of Notch1 and p65 protein was investigated by immunohistochemistry.
RESULTS: Statistically significant positive correlations were found between protein expression of Notch1 and p65 in both retrospective and prospective study cohorts. Patients with higher Notch1 expression showed a trend of having shorter survival time, whereas patients with lower Notch1 expression had better survival in both study cohorts. In multivariate analysis, Notch1 expression was proven to be an independent predictor of prognosis. Moreover, the prognostic value of Notch1 might differ according to p65 status.
CONCLUSIONS: Notch1 is an independent predictor of prognosis for patients with colorectal cancer. In addition, the predictive role of Notch1 on clinical outcome might be modified by p65 status, suggesting that targeting Notch1 and nuclear factor κB (NF-κB) might be a promising strategy for colorectal cancer treatment. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21771876     DOI: 10.1158/1078-0432.CCR-10-3196

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  18 in total

1.  Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.

Authors:  Shinya Morita; Yuji Nakamaru; Akihiro Homma; Shinichiro Yasukawa; Hiromitsu Hatakeyama; Tomohiro Sakashita; Satoshi Kano; Atsushi Fukuda; Satoshi Fukuda
Journal:  Int J Clin Oncol       Date:  2016-08-03       Impact factor: 3.402

2.  Role of epithelial-mesenchymal transition involved molecules in the progression of cutaneous melanoma.

Authors:  Daniela Murtas; Cristina Maxia; Andrea Diana; Luca Pilloni; Claudia Corda; Luigi Minerba; Sara Tomei; Franca Piras; Caterina Ferreli; Maria Teresa Perra
Journal:  Histochem Cell Biol       Date:  2017-08-21       Impact factor: 4.304

3.  SIRT3 inhibits cell proliferation in human gastric cancer through down-regulation of Notch-1.

Authors:  Liang Wang; Wei-Yan Wang; Li-Ping Cao
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Down-regulation of NOTCH1 and PKM2 can inhibit the growth and metastasis of colorectal cancer cells.

Authors:  Jia Wang; Meijuan Sun; Rong Ma; Gaobo Wang; Wenqing Li; Bowei Yang; Yang Yang
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

5.  Novel findings about management of gastric cancer: a summary from 10th IGCC.

Authors:  Danila Penon; Letizia Cito; Antonio Giordano
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

6.  Activated Notch1 expression is associated with angiogenesis in cutaneous melanoma.

Authors:  Daniela Murtas; Franca Piras; Luigi Minerba; Cristina Maxia; Caterina Ferreli; Paolo Demurtas; Simone Lai; Ester Mura; Michela Corrias; Paola Sirigu; Maria Teresa Perra
Journal:  Clin Exp Med       Date:  2014-07-18       Impact factor: 3.984

7.  Notch and TGF-β/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma.

Authors:  Jie Zhang; Yuan Wang; Dan Li; Shanghua Jing
Journal:  Tumour Biol       Date:  2013-08-06

Review 8.  NF-κB in colorectal cancer.

Authors:  Aristeidis G Vaiopoulos; Kalliopi Ch Athanasoula; Athanasios G Papavassiliou
Journal:  J Mol Med (Berl)       Date:  2013-05-01       Impact factor: 4.599

9.  Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival.

Authors:  Tadeu Ferreira Paiva; Victor Hugo Fonseca de Jesus; Raul Amorim Marques; Alexandre André Balieiro Anastácio da Costa; Mariana Petaccia de Macedo; Patricia Maria Peresi; Aline Damascena; Benedito Mauro Rossi; Maria Dirlei Begnami; Vladmir Cláudio Cordeiro de Lima
Journal:  BMC Cancer       Date:  2015-09-22       Impact factor: 4.430

10.  NDRG4 stratifies the prognostic value of body mass index in colorectal cancer.

Authors:  Jianyong Zheng; Yunming Li; Shaojun Zhu; Jipeng Li; Qingchuan Zhao; Gang Ji; Weizhong Wang; Dake Chu
Journal:  Oncotarget       Date:  2016-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.